Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 430 results for "cipla india"

Cipla Ties Up With Serum Institute to Sell Vaccines in South Africa
New Indian Express

Cipla Ties Up With Serum Institute to Sell Vaccines in South A...

MUMBAI: Cipla Ltd, India's fourth-largest drugmaker by sales, said on Thursday it had agreed to an exclusive deal with Serum Institute of India to supply vaccines to South Africa, adding a new market to their partnership in India and Europe. ... New Indian Express, 1 day ago
India's Cipla ties up with Serum..., 1 day ago

'Cipla's Ratings Unlikely to be Impacted by US Acquisitions'

Mumbai : India Ratings & Research on Wednesday said Cipla's ratings are unlikely to be affected by the recent cash-rich acquisitions of two US-based companies for $550 million. The current ratings of the company are assigned as 'IND AAA'/Stable.
 NDTV1 month ago Twin buy to help Cipla boost US presence  Calcutta Telegraph1 month ago Cipla Steps Up U.S. Expansion With $550 Million Acquisitions  Bloomberg1 month ago Cipla acquires generic businesses in US for $550 million  Livemint.com1 month ago
Financial Express

Stocks that are in focus today: Cipla, ONGC, Wipro and more

Cipla stocks will be in focus today as the the Indian generic drugmaker on Friday informed BSE that its UK arm, Cipla EU, has entered into definitive agreements to acquire two US-based companies InvaGen Pharmaceuticals Inc and Exelan Pharmaceuticals ...
 Financial Express1 month ago Stocks in focus: SBI, HDFC, Cipla and more  Business Today India1 month ago Cipla stock down over 4.5% despite strong Q1 results  Pharma Letter1 month ago Stocks that are in focus today: PSU banks, Tata Motors, Cipla and more  Financial Express1 month ago
VC Circle

Cipla to buy US-based InvaGen, Exelan for $550M

Indian drug major Cipla Ltd has agreed to acquire two US-based companies - InvaGen Pharmaceuticals Inc and Exelan Pharmaceuticals Inc - for a cash consideration of around $550 million (Rs 3,650 crore), it said on Friday. The deal, one of the ...
 VC Circle1 month ago Cipla: Growing stronger  Hindu Business Line1 month ago Cipla Expands Into The US With InvaGen & Exelan Acquistions  Asian Scientist3 weeks ago M & A On Their Mind?  Financial Express1 month ago

Cipla To Acquire 100% Of Generic Businesses In US For $550M

Reddit Email Print Reprint MUMBAI, India , Sept. 3, 2015 /PRNewswire/ --Cipla, a global pharmaceutical company which uses technology and innovation to meet the everyday needs of all patients, today announced that its UK arm, Cipla EU has ...
 TheStreet.com1 month ago US acquisitions give us complimentary portfolio of products: Cipla chief  Hindu Business Line1 month ago

GSK sinks Advair prices to fend off Cipla copycat in India

GlaxoSmithKline ($GSK) isn't just going to sit back and let Cipla's generic stomp all over asthma blockbuster Advair--known as Seretide outside the U.S.--in India. It's turning to a strategy it's used elsewhere to help its aging med compete, and ...
 FiercePharma2 months ago GSK halves seretide price to take on Cipla  Economic Times2 months ago

Stocks in focus today: Tata Steel, Cairn India and more

The BSE Sensex turned flat after opening over 80 points upon Thursday. NSE Niftyopened above 8,170. At 9.22 am, Sensex was down 33.47 points at 27,002.38. Similarly, Nifty was down 10.20 points at 8,167.20 during the same time. Below are the ...
 MSN News US23 hours ago Sensex Gains for Fifth Day in a Row, Nifty Ends Above 8,150  NDTV Profit3 days ago Sensex falls below 25K mark for the first time in 15 months; closes 308 points down at 24,894; Nifty ends at 7,559  Financial Express1 month ago Sensex ends 189 points down on weak rupee, Nifty below 8,500; Tata Steel, SBI gain  Financial Express1 month ago
Millennium Post

Ambanis are third richest Asian family with $21.5-bn net worth

As many as 14 Indian families have made it to the inaugural list of Forbes' 50 richest families in Asia, led by the Ambanis, who were ranked third on the list with a net worth of $21.5 billion. Indians hold 14 of the 50 spots, the most from any ...
 Millennium Post1 day ago 14 Indian families in Asia's richest list; Ambanis on 3rd  Times of India1 day ago 14 Indian families in Forbes 50 richest families in Asia; Ambanis on 3rd  Financial Express1 day ago Forbes' 50 richest families in Asia  MSN News US22 hours ago

Dug makers in India engineer hepatitis C cocktails impossible in West

Generic drug makers are working on a one-pill cocktail of the ingredients in Daklinza and Sovaldi that could compete with blockbuster Gilead drugs Ketaki GokhaleCaroline Chen Photo: Bloomberg Mumbai/San Francisco: Drug makers in India are hard ...
 Livemint.com1 day ago

Opening Bell | DLF, Accenture, Cipla in focus

Asian shares rose, taking a cue from a jump in oil prices as well as gains on the Wall Street A file photo of the BSE building in Mumbai. Photo: Mint Asian markets trade firm Asian shares rose on Friday, taking a cue from a jump in oil prices ...
 Livemint.com1 day ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less